We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FYBR
1976
DELISTED
Frontier Communications
FYBR
| $1.2M | ﹤0.01% |
+47,272
| New | +$1.14M |
|
1977
iShares Russell Mid-Cap Growth ETF
IWP
$19.5B
| $1.2M | ﹤0.01% |
+14,400
| New | +$1.21M |
|
|
AMBP.WS
1978
CALL
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
| $1.2M | ﹤0.01% |
250,000
-60,000
| -19% | -$26.5K |
|
|
XYZ
1979
PUT
Block Inc
XYZ
$49.2B
| $1.2M | ﹤0.01% |
19,100
-206,900
| -92% | -$12.8M |
|
|
NEX
1980
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.2M | ﹤0.01% |
+129,700
| New | +$1.27M |
|
1981
Freshworks
FRSH
$3.19B
| $1.2M | ﹤0.01% |
+81,274
| New | +$1.13M |
|
1982
Enel Chile
ENIC
$6.06B
| $1.19M | ﹤0.01% |
530,560
+364,982
| +220% | +$671K |
|
1983
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$76.7M
| $1.18M | ﹤0.01% |
10,200
+8,700
| +580% | +$982K |
|
1984
Erasca
ERAS
$6.11B
| $1.18M | ﹤0.01% |
+274,536
| New | +$1.86M |
|
1985
Markel Group
MKL
$25.4B
| $1.18M | ﹤0.01% |
+897
| New | +$1.11M |
|
1986
BrightView Holdings
BV
$1.25B
| $1.18M | ﹤0.01% |
+171,380
| New | +$1.32M |
|
1987
Simply Good Foods
SMPL
$926M
| $1.18M | ﹤0.01% |
31,000
-144,176
| -82% | -$5.32M |
|
1988
Dynatrace
DT
$12.9B
| $1.18M | ﹤0.01% |
+30,737
| New | +$1.12M |
|
1989
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $1.17M | ﹤0.01% |
20,012
-32,955
| -62% | -$2.2M |
|
|
API
1990
Agora
API
$333M
| $1.17M | ﹤0.01% |
299,211
-638,663
| -68% | -$2.11M |
|
|
SACH
1991
Sachem Capital Corp
SACH
$39.2M
| $1.17M | ﹤0.01% |
353,081
+282,901
| +403% | +$1.02M |
|
1992
Liberty Latin America Class A
LILA
$1.68B
| $1.16M | ﹤0.01% |
226,579
+127,768
| +129% | +$652K |
|
1993
Ingles Markets
IMKTA
$1.72B
| $1.16M | ﹤0.01% |
12,000
-9,895
| -45% | -$929K |
|
1994
Design Therapeutics
DSGN
$749M
| $1.16M | ﹤0.01% |
+112,818
| New | +$1.53M |
|
|
STR
1995
DELISTED
Sitio Royalties
STR
| $1.15M | ﹤0.01% |
40,007
-52,113
| -57% | -$1.51M |
|
|
OSG
1996
Octave Specialty Group
OSG
$258M
| $1.15M | ﹤0.01% |
+66,029
| New | +$981K |
|
1997
QCR Holdings
QCRH
$1.69B
| $1.14M | ﹤0.01% |
+22,981
| New | +$1.18M |
|
|
DENN
1998
DELISTED
Denny's
DENN
| $1.14M | ﹤0.01% |
123,606
-123,760
| -50% | -$1.34M |
|
1999
Ollie's Bargain Outlet
OLLI
$4.33B
| $1.14M | ﹤0.01% |
+24,300
| New | +$1.31M |
|
2000
Frontier Group Holdings
ULCC
$1.51B
| $1.14M | ﹤0.01% |
+110,779
| New | +$1.29M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.